← Back to Search
Neuroexcitatory Amino Acid Levels In Plasma And Cerebrospinal Fluid During Migraine Attacks
F. Martínez, J. Castilló, J. R. Rodríguez, R. Leira, M. Noya
Published 1993 · Medicine
Download PDFAnalyze on Scholarcy
A current hypothesis for migraine suggests that neuroexcitatory amino acids may participate in the triggering of attacks. To investigate this possibility we measured glutamic and aspartic acid level in plasma and cerebrospinal fluid (CSF) of patients with common and classic migraine during attacks, making comparisons with controls suffering from stress. Plasma levels of amino acids in migraine patients were lower than in controls. CSF concentrations of glutamic acid were higher in migraineurs than in controls. Our results suggest an excess of neuroexcitatory amino acids in the CNS of migraine patients during attacks, possibly favoring a state of neuronal hyperexcitability.
This paper references
Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?
A. Buchan (1990)
Tardive Long Lasting Hyperemia In Classic Migraine (Migraine With Aura)
A. Andersen (1987)
Is there a difference between classic and common migraine? What is migraine, after all?
D. Dalessio (1985)
Cortical Spreading Depression is Associated with Arachidonic Acid Accumulation and Preservation of Energy Charge
M. Lauritzen (1990)
Calcium Fluxes, Calcium Antagonists, and Calcium-Related Pathology in Brain Ischemia, Hypoglycemia, and Spreading Depression: A Unifying Hypothesis
B. Siesjö (1989)
Elevated concentrations of glutamate and aspartate in human ventricular cerebrospinal fluid (vCSF) during episodes of increased CSF pressure and clinical signs of impaired brain circulation
B. Engelsen (1985)
The nature of the chick's magnesium-sensitive retinal spreading depression
A. V. Harreveld (1984)
Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress
T. Murphy (1989)
Relationship between local changes in cortical blood flow and extracellular K+ during spreading depression.
A. Hansen (1980)
Ischemia may be the primary cause of the neurologic deficits in classic migraine.
T. Skyhøj Olsen (1987)
DOUBLE BLIND STUDY OF PROPRANOLOL FOR MIGRAINE PROPHYLAXIS
S. Diamond (1976)
The concept of migraine as a state of central neuronal hyperexcitability.
K. Welch (1990)
Methods for antagonizing glutamate neurotoxicity.
Choi Dw (1990)
Hypoxia/hypotension evoked release of glutamate and aspartate from the rat cerebral cortex
J. Phillis (1989)
Chinese Restaurant Syndrome
Liane Reif-Lehrer (1978)
Neurotransmitters and Drugs
Z. Kruk (1991)
PROPAGATION OF SPREADING CORTICAL DEPRESSION
A. A. P. Leão (1945)
Glutamate toxicity in a
Dilator effects of amino acid neurotransmitters on piglet pial arterioles.
D. Busija (1989)
Focal hyperemia followed by spreading oligemia and impaired activation of rcbf in classic migraine
J. Olesen (1981)
Neuroexcitatory plasma amino acids are elevated in migraine
M. Ferrari (1990)
The role of glutamate in neurotransmission and in neurologic disease.
J. T. Greenamyre (1986)
Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society.
Common and classic migraine. One or two entities?
V. Hachinski (1985)
Automatic recording apparatus for use in the chromatography of amino acids.
S. Moore (1958)
Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers
G. Alfredsson (1988)
Cortical spreading depression as a putative migraine mechanism
M. Lauritzen (1987)
Platelet Excitatory Aminoacids in Migraine
G. D'andrea (1989)
Brain pH in Migraine: An In Vivo Phosphorus-31 Magnetic Resonance Spectroscopy Study
K. Welch (1988)
This paper is referenced by
The Role of Kynurenine Pathway in Pain and Migraine
Zsófi A. Majláth (2015)
Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism.
N. Török (2016)
Protective compounds in animal models of trigeminal activation and neurodegeneration.
Enikő Vámos (2012)
Genome‐Wide‐Associated Variants in Migraine Susceptibility: A Replication Study From North India
J. Ghosh (2013)
Meta-analysis of genome-wide association for migraine in six population-based European cohorts
L. Ligthart (2011)
Spectrum of complicated migraine in children: A common profile in aid to clinical diagnosis.
Surya Prakash Gupta (2015)
Neurovascular Pharmacology of Prospective Antimigraine Drugs
K. Chan (2011)
Cerebrospinal Fluid Tyrosine and 3,4-Dihydroxyphenylacetic Acid Levels in Migraine Patients
J. Castillo (1996)
Cortical excitability in migraine
J. Áfra (2000)
Release of glutamate and CGRP from trigeminal ganglion neurons: Role of calcium channels and 5-HT1 receptor signaling
Y. Xiao (2008)
Protective compounds in animal models of trigeminal activation and neurodegeneration
A. Szent-Györgyi (2009)
Genotype–phenotype correlation in migraine without aura focusing on the rs1835740 variant on 8q22.1
A. F. Christensen (2011)
Trigeminal Mechanisms of Nociception
A. Andreou (2020)
A pharmacogenomic evaluation of migraine therapy
M. P. Johnson (2007)
Novel strategies for the treatment of migraine attacks via the CGRP, serotonin, dopamine, PAC1, and NMDA receptors
J. Tajti (2014)
Capillary Endothelial Na+, K+, ATPase Transporter Homeostasis and a New Theory for Migraine Pathophysiology
M. Harrington (2010)
Transient tritanopia in migraine: evidence for a large-field retinal abnormality in blue-yellow opponent pathways.
M. Tibber (2006)
Neuromodulation in Headache and Facial Pain Management: Principles, Rationale and Clinical Data
Paolo Martelletti (2020)
Cerebrospinal Fluid Analyses in Migraine Patients and Controls
J. Rothrock (1995)
Amino acid transmitters in patients with headache during the acute phase of cerebrovascular ischemic disease.
J. Castillo (1995)
Peripheral Biomarkers of Excitotoxicity in Neurological Diseases
L. Tremolizzo (2009)
Evaluation of Plasma Glutamate Levels in Normal Tension Glaucoma
H. Bunting (2009)
Current and novel insights into the neurophysiology of migraine and its implications for therapeutics
S. Akerman (2017)
Reference values of neuroactive amino acids in the cerebrospinal fluid by high-performance liquid chromatography with electrochemical and fluorescence detection.
V. Rizzo (1996)
Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine.
C. Ghelardini (2004)
Large-Scale Mass Spectrometry Imaging Investigation of Consequences of Cortical Spreading Depression in a Transgenic Mouse Model of Migraine
Ricardo J. Carreira (2015)
Visual spatial attention in migraine sufferers in postictal and interictal phases: An event-related potential study.
D. Koning (2001)
Selected Confirmed, Probable, and Exploratory Migraine Biomarkers
E. Loder (2006)
Kynurenines and headache
Á. Párdutz (2011)
Identification of Migraine Susceptibility Genes: Candidate Gene Studies
C. Gasparini (2014)
Cortical Spreading Depression: A Model for Understanding Migraine Biology and Future Drug Targets
K. Haerter (2005)
Topiramate in the treatment of migraine: A kainate (glutamate) receptor antagonist within the trigeminothalamic pathway
A. Andreou (2011)See more